Head and neck cancer among lifelong never-smokers and ever-smokers: Matched-pair analysis of outcomes after radiation therapy

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 34, Issue 3, 2011, Pages 270-275

  Chen, Allen M ^a   Chen, Leon M ^a   Vaughan, Andrew ^a   Farwell, Donald Gregory ^b   Luu, Quang ^b   Purdy, James A ^a   Vijayakumar, Srinivasan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

head and neck cancer; radiation therapy; smoking; squamous cell carcinoma; tobacco

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ETHNICITY; FEMALE; FOLLOW UP; GENDER; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PALATE; RADIATION DOSE; SMOKING; SURVIVAL RATE; SURVIVAL TIME; TONGUE; TONSIL; TOXICITY; TUMOR VOLUME;

ADULT; AGED; CALIFORNIA; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PHARYNGEAL NEOPLASMS; PROGNOSIS; RADIATION INJURIES; RADIOTHERAPY; SMOKING; TREATMENT OUTCOME;

EID: 79958245221     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181dea40b     Document Type: Article

References (40)

1. Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence. Cancer. 2007;110:1429-1435.
2. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988;48:3282-3287.
3. Lingen M, Sturgis EM, Kies MS. Squamous cell carcinoma of the head and neck in nonsmokers: clinical and biological characteristics and implications for management. Curr Opin Oncol. 2001;13:176-182. (Pubitemid 32433974)
4. Koch WM, Lango M, Sewell D, et al. Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope. 1999;109:1544-1551. (Pubitemid 29477216)
5. Sturgis EM, Wei Q. Genetic susceptibility: molecular epidemiology of head and neck cancer. Curr Opin Oncol. 2002;14:310-317. (Pubitemid 34492864)
6. Sorensen DM, Lewark TM, Haney JL, et al. Absence of p53 mutations in squamous cell carcinomas of the tongue in nonsmoking and nondrinking patients younger than 40 years. Arch Otolaryngol Head Neck Surg. 1997; 123:503-506. (Pubitemid 27212846)
7. Lingen MW, Chang KW, McMurray SJ, et al. Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9. Head Neck. 2000;22: 328-335. (Pubitemid 30413296)
8. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341-1346.
9. Brennan JA, Boyle JO, Koch WM, et al. Association between cigarette smoking and mutation of the p53 gene in squamous cell carcinoma of the head and neck. N Engl J Med. 1995;332:712-717.
10. Licitra L, Perrone F, Bossi P, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal sqamous cell carcinoma. J Clin Oncol. 2006;24:5630-5636. (Pubitemid 46631302)
11. Lindel K, Beer KT, Laissure J, et al. Human papillomavirus in positive squamous cell carcinoma of the oropharynx. Cancer. 2001;92:805-813.
12. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol. 2006;24:736-747. (Pubitemid 46622040)
13. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261-269. (Pubitemid 351480538)
14. Wiseman SM, Swede H, Stoler DL, et al. Squamous cell carcinoma of the head and neck in nonsmokers and nondrinkers: an analysis of clinicopathologic characteristics and treatment outcomes. Ann Surg Oncol. 2003;10:551-557. (Pubitemid 40486919)
15. Tan EH, Adelstein DJ, Droughton ML, et al. Squamous cell head and neck cancer in nonsmokers. Am J Clin Oncol. 1997;20:146-150. (Pubitemid 27152766)
16. Verschuur H, Irish JC, O'Sullivan B, et al. A matched control study of treatment outcome in young patients with squamous cell carcinoma of the head and neck. Laryngoscope. 1999;109:249-258. (Pubitemid 29075568)
17. Friedlander PL, Schantz SP, Shaha AR, et al. Squamous cell carcinoma of the tongue in young patients: a matched-pair analysis. Head Neck. 1998;20:363-368. (Pubitemid 28288056)
18. Siegelmann-Danieli N, Hanlon A, Ridge JA, et al. Oral tongue cancer in patients less than 45 years old: institutional experience and comparison with older patients. J Clin Oncol. 1998;16:745-753. (Pubitemid 28135624)
19. Pytynia KB, Grant JR, Etzel CJ, et al. Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck. J Clin Oncol. 2004;22:3981-3988. (Pubitemid 41079881)
20. Laurell G, Kraepelien T, Mavroidis P, et al. Stricture of the proximal esophagus in head and neck carcinoma patients after radiotherapy. Cancer. 2003;97:1693-1700. (Pubitemid 36350712)
21. Silvain C, Barrioz T, Besson I, et al. Treatment and long-term outcome of chronic radiation esophagitis after radiation therapy for head and neck tumors: a report of 13 cases. Dig Dis Sci. 1993;38:927-931. (Pubitemid 23144638)
22. Lawson JD, Otto K, Grist W, et al. Frequency of esophageal stenosis after simultaneous modulated accelerated radiation therapy and chemotherapy for head and neck cancer. Am J Otolaryngol. 2008;29:13-19. (Pubitemid 350180153)
23. Lee WT, Akst LM, Adelstein DJ, et al. Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiation. Head Neck. 2006;28:808-812. (Pubitemid 44320534)
24. Abdel-Wahab M, Abitbol A, Lewin A, et al. Quality-of-life assessment alter hyperfrationated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in inoperable and/or unresectable head and neck squamous cell carcinoma. Am J Clin Oncol. 2005;28:359-366. (Pubitemid 41099540)
25. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:7-16. (Pubitemid 30488207)
26. Eisbruch A, Lyden T, Bradford CR, et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Bio Phys. 2002;53:23-28. (Pubitemid 34465803)
27. Greven KM, White DR, Browne JD, et al. Swallowing dysfunction is a common sequelae after chemoradiation for oropharynx carcinoma. Am J Clin Oncol. 2008;31:209-212.
28. Logemann JA, Pauloski BR, Rademaker AW, et al. Swallowing disorders in the first year after radiation and chemoradiation. Head Neck. 2008;30:148-158. (Pubitemid 351251697)
29. Clark JR, McClyuskey SA, Hall F, et al. Predictors of morbidity following free flap reconstruction for cancer of the head and neck. Head Neck. 2007;29:1090-1101.
30. Eifel PJ, Jhingran A, Bodurka DC, et al. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol. 2002;20:3651-3657. (Pubitemid 34983225)
31. Benninger MS, Gillen J, Thieme P, et al. Factors associated with recurrence and vocal quality following radiation therapy for T1 and T2 glottic carcinomas. Laryngoscope. 1994;104:294-298. (Pubitemid 24085926)
32. Wong LS, Martins-Green M. Firsthand cigarette smoke alters fibroblast migration and survival: implications for impaired healing. Wound Repair Regen. 2004;12:471-484. (Pubitemid 39007048)
33. Van der Voet JC, Keus RB, Hart AA, et al. The impact of treatment time and smoking on local control and complications in T1 glottic cancer. Int J Radiat Oncol Biol Phys. 1998;42:247-255. (Pubitemid 28502769)
34. Rugg T, Saunders MI, Dische S. Smoking and mucosal reactions to radiotherapy. Br J Radiol. 1990;63:554-556. (Pubitemid 20218901)
35. Schantz SP, Hsu TC, Ainslie, et al. Young adults with head and neck squamous cell carcinoma. J Natl Cancer Inst. 1996;88:530-535. (Pubitemid 26118723)
36. Lin K, Patel SG, Chu PY, et al. Second primary malignancies of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx. Head Neck. 2005;27:1042-1048. (Pubitemid 41705581)
37. Lee WR, Berkey B, Marcial V, et al. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys. 1998;42:1069-1075. (Pubitemid 29004150)
38. Browman GP, Mohide EA, Willan A, et al. Association between smoking during radiotherapy and prognosis in head and neck cancer: a follow-up study. Head Neck. 2002;24:1031-1037. (Pubitemid 35379304)
39. Browman GP, Wong G, Hodson I, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. 1993;328:159-163. (Pubitemid 23021501)
40. Schultz CJ, Campbell BH, Reije JE, et al. Risk factors which predict persistent cancer in the abnormal larynx following definitive irradiation. Eur J Cancer B Oral Oncol. 1995;31:310-314. (Pubitemid 26017249)